Objective: To compare patients' attitudes towards recurrent prostate cancer (PCa) and starting hormone therapy (HT) treatment in two groups-Decision-Aid (DA) (intervention) and Standard-of-care (SoC) (Control).
Methods: The present research was conducted at three academic clinics-two in the Midwest and one in the Northeast U.S.